Company Filing History:
Years Active: 2020
Title: Lei Du-Cuny: Innovator in Pharmaceutical Compounds
Introduction
Lei Du-Cuny is a notable inventor based in Kelkheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
Among his latest patents are two innovative compounds. The first patent is for "Substituted 5-cyanoindole compounds and uses thereof." This compound has been shown to be useful for the treatment of lysine (K)-specific demethylase 1A (LSD1)-mediated diseases or disorders. The second patent is titled "Cyano-substituted indoles as LSD1 inhibitors." Similar to the first, this compound also targets LSD1-mediated diseases, showcasing the potential for therapeutic applications.
Career Highlights
Lei Du-Cuny is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions are vital in advancing treatments for complex medical conditions.
Collaborations
Lei has collaborated with esteemed colleagues, including Qitao Xiao and Guoliang Xun. These partnerships enhance the research efforts and foster innovation within the pharmaceutical field.
Conclusion
In summary, Lei Du-Cuny is a prominent inventor whose work in pharmaceutical compounds holds promise for the treatment of significant medical disorders. His patents reflect a commitment to advancing healthcare solutions.